Streptavidin-Coated Microplates enhance binding capabilities of biotinylated proteins, nucleic acids, and antigen-antibodies. Available in 96- or 384-well formats in clear, black, white, and black uClear, these products are offered in both pack and case quantities.
Low-volume, low-profile 384-well polypropylene microplate is offered for DNA, cDNA, and oligonucleotide microarrays, as well as for sample and compound storage. The plate features a 6.29-mm well depth that reduces sample volumes to as low as 2 μl.
LAB PAL Label Printer is a portable, easy-to-use printer with labels that withstand extreme laboratory environments. Built-in date/time stamp provides documentation directly on the label. Serialization feature and preprogrammed vial sizes (0.6-, 1.5-, and 2- to 4-ml) and slide labels save time.
Labjet benchtop printer provides self-adhesive labels for all types of labware. Enter desired text and print a pair of labels for the top and side of standard 1.5 to 2.0 ml microtubes.
Tip Refill System can be autoclaved. Polypropylene boxes accommodate 96 non-wettable virgin polypropylene tips in an 8 × 12-microplate format in sizes ranging from 10 to 1200 μl. These flip-top boxes may be opened and closed with one hand.
Sixteen-Well Reagent Reservoirs feature low binding polypropylene construction. They resist chemicals such as aggressive solvents. Pyramid bottom results in low dead volume and capacity is over 4 ml per column. The reservoirs comply with industry standards for automation.
Matrigel Matrix High Concentration (HC) is a solubilized basement membrane preparation extracted from EHS mouse sarcoma, a tumor rich in ECM proteins. Its major component is laminin, followed by collagen IV, heparin sulfate proteoglycans, and entactin.
BD BioCoat Angiogenesis System: Endothelial Cell Migration robust cell culture insert system is composed of a BD Falcon 24- or 96- multiwell insert plate containing a fluorescent blocking membrane and a microporous (3.
By Mark Terry Aurora kinases play a central role in controlling cell division, and have been implicated in many types of human cancer. They are shown to be deregulated in leukemia, colon, and breast cancers.
By Catherine Shaffer A team of researchers at Thomas Jefferson University, Philadelphia, led by Carlo Croce, MD, has created a powerful tool for the characterization of microRNAs or miRNAs, the newest members of the growing family of genetically significant small RNAs.
By Mark Terry CTI Molecular Imaging Inc., Knoxville, Tenn., announced at the 2004 annual meeting of the Society of Nuclear Medicine held the week of June 20th in Philadelphia, that it has formed a separate company
By Catherine Shaffer If you travel east through Quebec on the Trans-Canada Highway, you'll pass through cities such as Rouyn-Noranda, Val d'Or, Montreal, Drummondville, and Montmagny. Signs by the roadside help you navigate (in two languages).
By Mark Terry In a plenary talk given May 18, 2004, before the Cambridge Healthtech Institute World Congress for Success, Robert Ruffolo, Jr., PhD, president, Wyeth Research, and senior vice president, Wyeth Pharmaceuticals, Collegeville, Pa., focused much of the blame for the industry's declining productivity on over-regulation.
By Catherine Shaffer A new study published in Cancer Cell zeros in on the transcriptional regulator TAL1 (or SCL) as a culprit in the most deadly form of T cell acute lymphoblastic leukemia (T-ALL), accounting for a significant minority of all cases. Patients with T-ALL induced by TAL1 activation
By Don Monroe A small-molecule treatment for breast cancer that targets the urokinase-type plasminogen activator (uPA) system has entered phase I clinical trials. The Fox Chase Cancer Center, Philadelphia